SUDEEP PHARMA
Back to Income Statement
|
SUDEEP PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹139 Cr | ₹13 Cr | ₹62 Cr | ₹502 Cr | ₹33 Cr |
What is the latest Consolidated Net Profit of SUDEEP PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹139 Cr |
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹502 Cr |
| Mar2022 | ₹33 Cr |
How is Consolidated Net Profit of SUDEEP PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹139 Cr | 941.59 | |
| Mar2025 | ₹13 Cr | -78.63 | |
| Mar2024 | ₹62 Cr | -87.58 | |
| Mar2023 | ₹502 Cr | 1,404.62 | |
| Mar2022 | ₹33 Cr | - | |
Compare Consolidated Net Profit of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹12,544.3 Cr | 1.1% | 36.4% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | 1.1% |
36.4% |
|
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses